Accelerate Diagnostics | AXDX - SCHULD



SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Danaher USD 18.48B 66M 2026-03
Illumina USD 2.55B 23M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Quidel USD 2.83B 9.9M 2025-12
Revvity USD 3.4B 29.2M 2025-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12